Abstract
Background
Proven short-term effectiveness of obesity therapy should be re-evaluated in the long-term. The objective of this paper is to determine the long-term (10 years) outcome for patients from a randomised controlled trial (RCT).
Methods
A RCT in 2002 compared laparoscopic adjustable gastric band (LAGB) for obesity with non-surgical therapy. Follow-up has been conducted at 10 years. Eighty patients (BMI 30–35) were randomised to a non-surgical or a surgical program. Outcome data are available on 37 (92.5 %) of the surgical patients and 27 (62.5 %) of the non-surgical patients at 10 years.
Results
Weight change, the metabolic syndrome, quality of life, adverse events and direct costs of the surgical cohort were the main results of the study. A durable weight loss is present in the surgical group with a mean (SD) 10-year weight loss of 14.1 (7.7) kg (63.4 % EWL), better than the non-surgical group (mean (SD) = 0.4 (10.5) kg; p < 0.001). The metabolic syndrome was reduced from 14 to 4 of the 37 patients who completed 10 years within the LAGB groups. Proximal gastric enlargements occurred in 17 (30 %) of the 57 who had LAGB and removal of the band occurred in 7 (12 %). The annual maintenance costs including additional surgery was AUD $765 per patient per year.
Conclusions
Bariatric surgery with the LAGB can achieve long-term weight reduction which is better than a program of non-surgical therapy. There is also a sustained reduction of the metabolic syndrome. There is a significant maintenance requirement after LAGB.
Similar content being viewed by others
References
Flegal KM, Carroll MD, Kit BK, et al. Prevalence of obesity and trends in the distribution of body mass index among us adults, 1999–2010. JAMA. 2012;307:491–7.
World Health Organization. Obesity and overweight fact sheet no 311. 2011.
Avenell A, Brown TJ, McGee MA, et al. What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials. J Hum Nutr Diet. 2004;17:317–35.
Avenell A, Brown TJ, McGee MA, et al. What interventions should we add to weight reducing diets in adults with obesity? A systematic review of randomized controlled trials of adding drug therapy, exercise, behaviour therapy or combinations of these interventions. J Hum Nutr Diet. 2004;17:293–316.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.
Chapman AE, Kiroff G, Game P, et al. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery. 2004;135:326–51.
Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142:547–59.
O’Brien P, McPhail T, Chaston T, et al. Systematic review of medium term weight loss after bariatric surgery. Obes Surg. 2006;16:1032–40.
Flum DR, Belle SH, King WC, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361:445–54.
O’Brien P, McDonald L, Anderson M, et al. Long term outcomes after bariatric surgery: fifteen year follow up after gastric banding and a systematic review of the literature. Ann Surg. 2013;257:87–94.
Cobourn C, Mumford D, Chapman MA, et al. Laparoscopic gastric banding is safe in outpatient surgical centers. Obes Surg. 2010;20:415–22.
O’Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med. 2006;144:625–33.
Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316–23.
Keating CL, Dixon JB, Moodie ML, et al. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care. 2009;32:567–74.
Keating CL, Dixon JB, Moodie ML, et al. Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized controlled trial. Diabetes Care. 2009;32:580–4.
Picot J, Jones J, Coquitt JL, et al. Weight loss surgery for mild to moderate obesity: a systematic review and economic evaluation. Obes Surg. 2012;22:1496–506.
Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among us adults: findings from the third national health and nutrition examination survey. JAMA. 2002;287:356–9.
Ware J. Sf-36 health survey: manual and interpretation guide. Boston: The Health institute, New England Medical Center; 1997.
Statistics ABo. National health survey Sf-36 population norms for Australia. 1995.
Miller K, Pump A, Hell E. Vertical banded gastroplasty versus adjustable gastric banding: prospective long-term follow-up study. Surg Obes Relat Dis. 2007;3:84–90.
Favretti F, Segato G, Ashton D, et al. Laparoscopic adjustable gastric banding in 1,791 consecutive obese patients: 12-year results. Obes Surg. 2007;17:168–75.
Lanthaler M, Aigner F, Kinzl J, et al. Long-term results and complications following adjustable gastric banding. Obes Surg. 2010;20:1078–85.
Naef M, Mouton W, Naef U, et al. Graft survival and complications after laparoscopic gastric banding for morbid obesity—lessons learned from a 12-year experience. Obes Surg. 2010;20:1206–14.
Himpens J, Cadiere GB, Bazi M, et al. Long-term outcomes of laparoscopic adjustable gastric banding. Arch Surg. 2011;146:802–7.
Stroh C, Hohmann U, Schramm H, et al. Fourteen-year long-term results after gastric banding. Journal of Obesity. 2011;2011:128451–7.
Fobi MA. Vertical banded gastroplasty vs gastric bypass: 10 years follow-up. Obes Surg. 1993;3:161–4.
Wolfel R, Gunther K, Rumenapf G, et al. Weight reduction after gastric bypass and horizontal gastroplasty for morbid obesity. Results after 10 years. Eur J Surg. 1994;160:219–25.
Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339–50.
Sugerman HJ, Wolfe LG, Sica DA, et al. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg. 2003;237:751–6. discussion 757–758.
Günther K, Vollmuth J, Weißbach R, et al. Weight reduction after an early version of the open gastric bypass for morbid obesity: results after 23 years. Obes Surg. 2006;16:288–96.
Christou NV, Look D, MacLean LD. Weight gain after short- and long-term gastric bypass in patients followed for longer than 10 years. Ann Surg. 2006;244:734–40.
Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.
Higa K, Ho T, Tercero F, et al. Laparoscopic roux-en-y gastric bypass: 10-year follow-up. Surg Obes Relat Dis. 2011;7:516–25.
Hall JC, Watts JM, O’Brien PE, et al. Gastric surgery for morbid obesity. The Adelaide study Annals of Surgery. 1990;211:419–27.
O’Brien PE, Dixon JB. Pars flaccida versus perigastric pathways for the placement of the lapband(r) system (abstract). Obes Surg. 2003;13:211.
Dixon AF, Dixon JB, O’Brien PE. Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study. J Clin Endocrinol Metab. 2005;90:813–9.
Burton PR, Yap K, Brown WA, et al. Changes in satiety, supra- and infraband transit, and gastric emptying following laparoscopic adjustable gastric banding: a prospective follow-up study. Obes Surg. 2011;21:217–23.
Clinical Issues Committee A. Bariatric surgery in class I obesity (body mass index 30–35 kg/m(2)). Surg Obes Relat Dis. 2013;9:e1–e10.
Conflict of Interest Disclosure Statement
The Centre for Obesity Research and Education (CORE) at Monash University receives grants from Allergan Inc and Applied Medical for research and educational support. The grants are not tied to any specified research projects and the grantors has no control of the protocol, analysis and reporting of any studies.
Dr. Wendy Brown received an Honorarium from Allergan to attend a Surgical Advisory Panel in London in 2009.
Dr Paul O’Brien has written a patient information book entitled "The Lap-Band Solution: A Partnership for Weight Loss" which is given to patients without charge but some are sold to surgeons and others for which he receives a royalty. He is employed as the National Medical Director for the American Institute of Gastric Banding, a multicenter facility, based in Dallas, Texas, that treats obesity predominantly by gastric banding.
Grant Support
The study has been funded by a research grants from Monash University and from Inamed Health, manufacturer of the Lap-Band system. Equipment, devices and products were provided by Inamed Health, Novartis, manufacturer of Optifast and Applied Medical and US Surgical, manufacturers of laparoscopic disposable equipment.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
O’Brien, P.E., Brennan, L., Laurie, C. et al. Intensive Medical Weight Loss or Laparoscopic Adjustable Gastric Banding in the Treatment of Mild to Moderate Obesity: Long-Term Follow-up of a Prospective Randomised Trial. OBES SURG 23, 1345–1353 (2013). https://doi.org/10.1007/s11695-013-0990-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-013-0990-3